Oncolytics Biotech Inc T.ONC

posted this on nov. 4, now we know what was fishy

[itntdf]

this was taken from oncy's press release:

"Oncolytics expects to finalize the definitive agreements within the next 90 days and open the Precision Promise investigational treatment of pelareorep, checkpoint inhibitor, gemcitabine, and nab-paclitaxel in early 2024."

no mention was made that inclusion in precision promise came late in the game.  it was clearly stated there was a 90 day timeframe to finalize the agreement.

the only thing which came "late in the game" seems to be the additonal $5 million grant.  but that was for an additional study and wouldn't seem to have been anything which would have held up the "original" agreement finalization.

guess one could say that H1 2024 is early '24 since H2 in comparison would be late '24.

"late in the game" sounds like a red herring and something IS fishy.

can't think of any real reason matt et al could not have said SOMETHING about the agreement timetable since it is an obvious prerequisite to the trial.

NOW WE KNOW why matt didn't say anything about the agreement.

[13X2413]

Nailed it!

[13X2413]

The big question is......now what???

[Buckhenry]

Waiting to buy below a buck. Those who don't learn from history are destined to repeat it. Right pumpers....

[Lesalpes29]

Not sure greedy Matt but I think BP are squeezing your B... actually! Humour only, what else we can do! Lol

[venture009]

ITNTDF, again management has miss judged what the market was expecting from an announcement perspective and the sp is getting hammered as a result. The results were very good and yet the market has totally rejected them and punished the sp. Will BP at some point step in? Why should they when the price keeps getting cheaper. 

[pelaboost]

@itntdf. You were correct. First, I should say I think PanCAN is a fine organization. However, I did ask several weeks ago if we really needed PanCAN. From my lay perspective I was trying to imagine the thinking of an entity that might be spending a billion of more. I thought PanCAN with all their strengths just might be in the way. I am now going to spend a considerable amount of time updating

[Peladawn]

Pelaboost....spot on post....I too will be adding......a lot!

[Quentin30]

why buy now.. in order to run its Phase III in Panc, the cost has just risen from 30 million to 80 million... ONCY has 40 million in cash... so, without a partner, who will be paying for this additional 50 million... Buying now, in the HOPE that a partner will pay for this trial is very risky... and raising money in this market is likely to be massively dilutive. A potential partner such as Roche

[itntdf]

This post has been removed in accordance with Community Policy